This came after Sun Pharma presented the BE study report along with revised clinical trial (CT) protocol no. ICR/23/013 ver.

The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales of compounded semaglutide hard and lambasting the pharma industry ...

Novo Nordisk cautions pharmacies and individuals to only purchase Ozempic® (semaglutide) injection 1 mg and other semaglutide-containing medicines through authorized distributors of Novo ...

the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that "several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg" were in the U.S ...

The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout ...

April 14, 2025 — The FDA and the maker of the popular diabetes and weight loss drug Ozempic are warning people not to use counterfeit semaglutide 1.0 milligrams — the Ozempic injection ...

PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ -- Novo Nordisk has become aware of several hundred units of Ozempic® (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized ...

Eli Lilly and Novo Nordisk enjoy the highest values in the pharma ... generic semaglutide—particularly given the ...